Abduljawad KA, Langley RW, Bradshaw CM, Szabadi E (1997) Effects of clonidine and diazepam on the acoustic startle response and on its inhibition by “prepulses” in man. J Psychopharmacol 11:29–34

Article  CAS  PubMed  Google Scholar 

Abrahams S, Leigh PN, Goldstein LH (2005) Cognitive change in ALS: a prospective study. Neurology 64:1222–1226

Article  CAS  PubMed  Google Scholar 

Anderson LL, Absalom NL, Abelev SV, Low IK, Doohan PT, Martin LJ, Chebib M, McGregor IS, Arnold JC (2019) Coadministered cannabidiol and clobazam: preclinical evidence for both pharmacodynamic and pharmacokinetic interactions. Epilepsia 60:2224–2234

Article  CAS  PubMed  PubMed Central  Google Scholar 

Anderson LL, Low IK, McGregor IS, Arnold JC (2020) Interactions between cannabidiol and Δ(9) -tetrahydrocannabinol in modulating seizure susceptibility and survival in a mouse model of Dravet syndrome. Br J Pharmacol 177:4261–4274

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bachmanov AA, Reed DR, Beauchamp GK, Tordoff MG (2002) Food intake, water intake, and drinking spout side preference of 28 mouse strains. Behav Genet 32:435–443

Article  PubMed  PubMed Central  Google Scholar 

Bakshi VP, Geyer MA (1998) Multiple limbic regions mediate the disruption of prepulse inhibition produced in rats by the noncompetitive NMDA antagonist dizocilpine. J Neurosci 18:8394–8401

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barber SC, Shaw PJ (2010) Oxidative stress in ALS: key role in motor neuron injury and therapeutic target. Free Radical Biol Med 48:629–641

Article  CAS  Google Scholar 

Berry JD, Shefner JM, Conwit R, Schoenfeld D, Keroack M, Felsenstein D, Krivickas L, David WS, Vriesendorp F, Pestronk A, Caress JB, Katz J, Simpson E, Rosenfeld J, Pascuzzi R, Glass J, Rezania K, Rothstein JD, Greenblatt DJ, Cudkowicz ME (2013) Design and initial results of a multi-phase randomized trial of ceftriaxone in amyotrophic lateral sclerosis. PLoS One 8:e61177

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bilsland LG, Dick JR, Pryce G, Petrosino S, Di Marzo V, Baker D, Greensmith L (2006) Increasing cannabinoid levels by pharmacological and genetic manipulation delay disease progression in SOD1 mice. Faseb J 20:1003–1005

Article  CAS  PubMed  Google Scholar 

Bocchio M, McHugh SB, Bannerman DM, Sharp T, Capogna M (2016) Serotonin, amygdala and fear: assembling the puzzle. Front Neural Circuits 10:24

Article  PubMed  PubMed Central  Google Scholar 

Bouteloup C, Desport JC, Clavelou P, Guy N, Derumeaux-Burel H, Ferrier A, Couratier P (2009) Hypermetabolism in ALS patients: an early and persistent phenomenon. J Neurol 256:1236–1242

Article  CAS  PubMed  Google Scholar 

Browne SE, Yang L, DiMauro JP, Fuller SW, Licata SC, Beal MF (2006) Bioenergetic abnormalities in discrete cerebral motor pathways presage spinal cord pathology in the G93A SOD1 mouse model of ALS. Neurobiol Dis 22:599–610

Article  CAS  PubMed  Google Scholar 

Burghardt NS, Sullivan GM, McEwen BS, Gorman JM, LeDoux JE (2004) The selective serotonin reuptake inhibitor citalopram increases fear after acute treatment but reduces fear with chronic treatment: a comparison with tianeptine. Biol Psychiatry 55:1171–1178

Article  CAS  PubMed  Google Scholar 

Campos AC, Guimarães FS (2008) Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats. Psychopharmacology 199:223–230

Article  CAS  PubMed  Google Scholar 

Cheng D, Low JK, Logge W, Garner B, Karl T (2014a) Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1∆E9 mice. Psychopharmacology 231:3009–3017

Article  CAS  PubMed  Google Scholar 

Cheng D, Spiro AS, Jenner AM, Garner B, Karl T (2014b) Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimer’s disease transgenic mice. J Alzheimers Dis 42:1383–1396

Article  CAS  PubMed  Google Scholar 

Choi CI, Lee YD, Gwag BJ, Cho SI, Kim SS, Suh-Kim H (2008) Effects of estrogen on lifespan and motor functions in female hSOD1 G93A transgenic mice. J Neurol Sci 268:40–47

Article  CAS  PubMed  Google Scholar 

Ciryam P, Lambert-Smith IA, Bean DM, Freer R, Cid F, Tartaglia GG, Saunders DN, Wilson MR, Oliver SG, Morimoto RI, Dobson CM, Vendruscolo M, Favrin G, Yerbury JJ (2017) Spinal motor neuron protein supersaturation patterns are associated with inclusion body formation in ALS. Proc Natl Acad Sci 114:E3935–E3943

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cocozza G, Garofalo S, Morotti M, Chece G, Grimaldi A, Lecce M, Scavizzi F, Menghini R, Casagrande V, Federici M, Raspa M, Wulff H, Limatola C (2021) The feeding behaviour of Amyotrophic Lateral Sclerosis mouse models is modulated by the Ca(2+) -activated K(Ca) 3.1 channels. Br J Pharmacol 178:4891–4906

Article  CAS  PubMed  Google Scholar 

Coles M, Watt G, Kreilaus F, Karl T (2020) Medium-dose chronic cannabidiol treatment reverses object recognition memory deficits of APP (Swe) /PS1ΔE9 transgenic female mice. Front Pharmacol 11:587604

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cudkowicz M, McKenna-Yasek D, Sapp P, Chin W, Geller B, Hayden D, Schoenfeld D, Hosler B, Horvitz H, Brown R (1997) Epidemiology of mutations in superoxide dismutase in amyotrophic lateal sclerosis. Ann Neurol 41:210–221

Article  CAS  PubMed  Google Scholar 

Dentel C, Palamiuc L, Henriques A, Lannes B, Spreux-Varoquaux O, Gutknecht L, Rene F, Echaniz-Laguna A, Gonzalez de Aguilar JL, Lesch KP, Meininger V, Loeffler JP, Dupuis L (2013) Degeneration of serotonergic neurons in amyotrophic lateral sclerosis: a link to spasticity. Brain : J Neurol 136:483–493

Article  Google Scholar 

Dharmadasa T, Henderson RD, Talman PS, Macdonell RA, Mathers S, Schultz DW, Needham M, Zoing M, Vucic S, Kiernan MC (2017) Motor neurone disease: progress and challenges. Med J Aust 206:357–362

Article  PubMed  Google Scholar 

Dupuis L, Oudart H, René F, Gonzalez de Aguilar JL, Loeffler JP (2004) Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proc Natl Acad Sci U S A 101:11159–11164

Article  CAS  PubMed  PubMed Central  Google Scholar 

Esposito G, Scuderi C, Savani C, Steardo L Jr, De Filippis D, Cottone P, Iuvone T, Cuomo V, Steardo L (2007) Cannabidiol in vivo blunts β-amyloid induced neuroinflammation by suppressing IL-1β and iNOS expression. Br J Pharmacol 151:1272–1279

Article  CAS  PubMed  PubMed Central  Google Scholar 

Esposito G, Scuderi C, Valenza M, Togna GI, Latina V, De Filippis D, Cipriano M, Carratù MR, Iuvone T, Steardo L (2011) Cannabidiol reduces Aβ-induced neuroinflammation and promotes hippocampal neurogenesis through PPARγ involvement. PLoS One 6:e28668–e28668

Article  CAS  PubMed  PubMed Central  Google Scholar 

Evans MC, Serres S, Khrapitchev AA, Stolp HB, Anthony DC, Talbot K, Turner MR, Sibson NR (2014) T₂-weighted MRI detects presymptomatic pathology in the SOD1 mouse model of ALS. J Cereb Blood Flow Metab 34:785–793

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ferrante RJ, Browne SE, Shinobu LA, Bowling AC, Baik MJ, MacGarvey U, Kowall NW, Brown RH Jr, Beal MF (1997) Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J Neurochem 69:2064–2074

Article  CAS  PubMed  Google Scholar 

Ferrante KL, Shefner J, Zhang H, Betensky R, O’Brien M, Yu H, Fantasia M, Taft J, Beal MF, Traynor B, Newhall K, Donofrio P, Caress J, Ashburn C, Freiberg B, O’Neill C, Paladenech C, Walker T, Pestronk A, Abrams B, Florence J, Renna R, Schierbecker J, Malkus B, Cudkowicz M (2005) Tolerance of high-dose (3,000 mg/day) coenzyme Q10 in ALS. Neurology 65:1834–1836